MarketPeel
Insider Trading Intelligence
Pricing
…
RT

Richard Nolan Townsend

LXEO
CHIEF EXECUTIVE OFFICER · LEXEO THERAPEUTICS, INC. · CIK 0001995218
FILING MIX · LIFETIME38%/62%
BUYS
19
SELLS
31
TOTAL VALUE
$2.06M
COMPANIES
1
ACTIVE SINCE
Jan 2024
HOLDINGS NOW
377,817
AVG SELL PX
$9.42
TRADE KIND
SHOWING 50 / 50
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
21 backtested trades · 8 horizons · 28 pending
Forward-return performance of every backtestable P/S trade by Richard Nolan Townsend, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d21+76.19%-10.92%+0.74%-11.67%-10.23%—
14d21+71.43%-9.07%+0.51%-9.58%-10.88%—
30d21+66.67%-8.30%+0.75%-9.04%-5.48%—
60d21+61.90%-6.81%+1.99%-8.80%-24.28%—
90d21(1 pending)+85.00%-18.10%+3.66%-21.77%-35.99%—
180d21(2 pending)+78.95%-29.39%+6.51%-35.90%-61.02%—
1y21(7 pending)+64.29%-34.57%+15.41%-49.98%-83.65%—
2y21(18 pending)+100.00%-70.86%+39.84%-110.69%-115.12%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LXEO · 377,817 shares · as of Jul 1, 2026
0161,666323,333484,999646,66520252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 19 buys / 31 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
25,947$4.48$116.2K377,817Jul 1, 2026Jul 1, 2026 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
67,000——403,764Jun 29, 2026Jul 1, 2026 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
3,342$5.06$16.9K336,764May 18, 2026May 20, 2026 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
55,000$5.69$313.1K340,106Apr 6, 2026Apr 7, 2026 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,623$2.64$6.9K395,106Mar 13, 2026Mar 17, 2026 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
10,173$6.38$64.9K392,483Feb 18, 2026Feb 20, 2026 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
646,665——646,665Feb 4, 2026Feb 6, 2026 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
161,665——402,656Feb 4, 2026Feb 6, 2026 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
1,127$9.27$10.4K240,991Nov 18, 2025Nov 20, 2025 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
12,985$8.94$116.0K242,266Oct 17, 2025Oct 17, 2025 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
148$9.56$1.4K242,118Oct 17, 2025Oct 17, 2025 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
33,000——255,251Oct 15, 2025Oct 17, 2025 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,193$2.64$5.8K222,251Sep 12, 2025Sep 16, 2025 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
2,735$4.67$12.8K220,058Aug 18, 2025Aug 20, 2025 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
1,115$4.67$5.2K220,058Aug 18, 2025Sep 10, 2025 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
1,074$2.77$3.0K221,173May 16, 2025May 20, 2025 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,128$2.61$5.6K222,247Mar 14, 2025Apr 1, 2025 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
4,326$4.41$19.1K220,119Feb 19, 2025Feb 21, 2025 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
207,500——207,500Jan 7, 2025Jan 10, 2025 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
103,750——224,445Jan 7, 2025Jan 10, 2025 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
2,500——118,655Dec 10, 2024Dec 11, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
2,500$2.33$5.8K123,195Dec 10, 2024Dec 11, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,500$8.20$20.5K120,695Dec 10, 2024Dec 11, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
2,500$2.33$5.8K123,195Nov 11, 2024Nov 13, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,500$7.82$19.6K120,695Nov 11, 2024Nov 13, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
2,500——121,155Nov 11, 2024Nov 13, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,000$8.10$40.5K120,695Oct 10, 2024Oct 15, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
5,000——123,655Oct 10, 2024Oct 15, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
5,000$2.33$11.7K125,695Oct 10, 2024Oct 15, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,000$10.65$53.3K120,695Sep 10, 2024Sep 11, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
5,000——128,655Sep 10, 2024Sep 11, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
5,000$2.33$11.7K125,695Sep 10, 2024Sep 11, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
5,000$2.33$11.7K125,695Aug 12, 2024Aug 13, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,000$11.53$57.6K120,695Aug 12, 2024Aug 13, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
5,000——133,655Aug 12, 2024Aug 13, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
27,931$17.06$476.5K120,795Jul 11, 2024Jul 12, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100$19.06$1.9K120,695Jul 11, 2024Jul 12, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
5,000——138,655Jul 10, 2024Jul 12, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
5,000$2.33$11.7K175,695Jul 10, 2024Jul 12, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
23,622$16.45$388.6K152,073Jul 10, 2024Jul 12, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,347$16.85$56.4K148,726Jul 10, 2024Jul 12, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
5,000$2.33$11.7K175,695Jun 10, 2024Jun 12, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,038$18.18$37.1K170,695Jun 10, 2024Jun 12, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,962$17.29$51.2K172,733Jun 10, 2024Jun 12, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
5,000——143,655Jun 10, 2024Jun 12, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE
Chief Executive Officer
5,000$2.33$11.7K148,655May 13, 2024May 14, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
5,000$2.33$11.7K175,695May 13, 2024May 14, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,000$13.22$66.1K170,695May 13, 2024May 14, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
262,500——262,500Jan 5, 2024Jan 9, 2024 ↗View →
LXEO
LEXEO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
43,750——170,695Jan 5, 2024Jan 9, 2024 ↗View →
Other insiders · LXEO
Loading peer insiders…
About this filer
CIK 0001995218
ROLE
Chief Executive Officer
PRIMARY
LXEO
COMPANIES
1
ACTIVE SINCE
Jan 2024
MARKETPEEL · /INSIDER/0001995218DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback